Studies have shown that tDCS and foot drop stimulator treatment improve motor dysfunction in stroke patients, increase brain-derived neurotrophic factor, interleukin-10, and reduce interleukin-6 and tumor necrosis factor-alpha levels,[163] demonstrating the effect of the combination of tDCS and foot drop stimulator on neuroplasticity biomarkers. This evidence concerns the gene BDNF and stroke disorder.